Tuesday, 7 July 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 07 July 2026
News

J&J to pull drug worldwide

Posted 7 July 2026 PM

Johnson & Johnson has confirmed it is discontinuing Eprex globally, with the long-standing anaemia therapy to be removed from the Australian market in the coming months.

It comes after the US pharma giant notified the TGA of its decision to discontinue Eprex in Australia on 30 September, citing “commercial changes” and “commercial viability” as the reason.

To see the whole article, please login

Popular

Blockbusters stuck in PBS limbo
Pharma Wonderland opens in Sydney
Next era of blockbusters unveiled
New FY brings fresh career start
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (23)

Access & Reimbursement (1)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home